Perbak Capital Partners LLP United Therapeutics Corp Transaction History
Perbak Capital Partners LLP
- $442 Billion
- Q2 2025
A detailed history of Perbak Capital Partners LLP transactions in United Therapeutics Corp stock. As of the latest transaction made, Perbak Capital Partners LLP holds 723 shares of UTHR stock, worth $320,607. This represents 0.05% of its overall portfolio holdings.
Number of Shares
723Holding current value
$320,607% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
745Shares Held
44.1MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.43 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.97 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.05 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$961 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$940 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $20.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...